UltraTouch starts Palpagraph breast mapping trials:
This article was originally published in Clinica
Executive Summary
UltraTouch is starting clinical trials for a breast mapping technology, which it claims can map tumours 16 times smaller than those detected by hand - which are smaller than those routinely detected by mammography in premenopausal women. The Palpagraph scans the breast by computer-controlled mechanical palpation (light touch). It uses no radiation and is painless. The information is collected and stored in medical records as a standardised BreastMap. UltraTouch of Exton, Philadelphia, plans to use the clinical trial data to support applications to market the device in the US and Europe.